Axiodis CRO
A French specialist in clinical biometrics & data management — the cornerstone of the Oxurion buy-and-build platform.
About Axiodis
Axiodis is a French clinical research organization specialized in biometrics, clinical data management and biostatistics. Through its proprietary Exagis platform and regulatory expertise, Axiodis supports biotech, pharmaceutical, medtech and academic sponsors in the execution of complex clinical studies.
In 2024, Oxurion acquired a 72% controlling stake in Axiodis SAS, establishing it as the operational cornerstone of its European CRO platform. The acquisition provides Oxurion with deep biometric expertise, a ready-to-scale clinical operations team, and the proprietary Exagis platform — underpinning its buy-and-build consolidation strategy across European clinical research.
Biometrics & Data Management
End-to-end clinical data management, database design, data review, query management and data lock for Phase I–IV studies.
Biostatistics
Statistical analysis plans, randomization, interim analyses, integrated summaries, and regulatory submission packages.
Regulatory Submissions
Clinical Study Reports (CSRs), ISS/ISE, eCTD formatting and regulatory document review across FDA, EMA and national agencies.
Medical Writing
Protocol development, investigator brochures, clinical study reports and publication support — authored to GCP and ICH standards.
Clinical Operations
Site selection, monitoring, patient recruitment strategy and project management for complex multi-country Phase II/III studies.
Pharmacovigilance
Safety data management, SAE processing, aggregate reporting and pharmacovigilance system master file (PSMF) support.
Exagis eCRF platform
Axiodis operates Exagis, its proprietary next-generation eCRF and clinical data management platform. Purpose-built for biometrics-heavy studies, Exagis streamlines data collection, query management, data review and statistical outputs — reducing timelines and regulatory risk.